Anemia, Blood Transfusion Requirements and Mortality Risk in Human Immunodeficiency Virus-Infected Adults Requiring Acute Medical Admission to Hospital in South Africa
Open Access
- 12 November 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 2 (4) , ofv173
Abstract
Background. Morbidity and mortality remain high among hospitalized patients infected with human immunodeficiency virus (HIV) in sub-Saharan Africa despite widespread availability of antiretroviral therapy. Severe anemia is likely one important driver, and some evidence suggests that blood transfusions may accelerate HIV progression and paradoxically increase short-term mortality. We investigated the relationship between anemia, blood transfusions, and mortality in a South African district hospital. Methods. Unselected consecutive HIV-infected adults requiring acute medical admission to a Cape Town township district hospital were recruited. Admission hemoglobin concentrations were used to classify anemia severity according to World Health Organization/AIDS Clinical Trials Group criteria. Vital status was determined at 90 days, and Cox regression analyses were used to determine independent predictors of mortality. Results. Of 585 HIV-infected patients enrolled, 578 (98.8%) were included in the analysis. Anemia was detected in 84.8% of patients and was severe (hemoglobin, 6.5–7.9 g/dL) or life-threatening (hemoglobin, Conclusions. Newly admitted HIV-infected adults had a high prevalence of severe or life-threatening anemia and blood transfusions were frequently required. However, after adjustment for confounders, blood transfusions did not confer an increased mortality risk.Keywords
Funding Information
- Wellcome Trust
- Wellcome Trust (088590, 098316, 085251)
- Global Clinical Trials
- Medical Research Council/Department for International Development
- Wellcome Trust (MR/M007375/1)
- National Research Foundation of South Africa (UID 85858)
This publication has 37 references indexed in Scilit:
- Prevalent and Incident Tuberculosis Are Independent Risk Factors for Mortality among Patients Accessing Antiretroviral Therapy in South AfricaPLOS ONE, 2013
- Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART RegimenJournal of Tropical Medicine, 2013
- Antiretroviral treatment reverses HIV-associated anemia in rural TanzaniaBMC Infectious Diseases, 2011
- Anemia in Human Immunodeficiency Virus–Infected and Uninfected Women in RwandaThe American Journal of Tropical Medicine and Hygiene, 2011
- The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic bloodJournal of Blood Medicine, 2011
- Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort studyBMC Public Health, 2010
- Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in TanzaniaBMC Infectious Diseases, 2008
- Laboratory costs of a hospital-based blood transfusion service in MalawiJournal of Clinical Pathology, 2007
- Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis controlAIDS, 2006
- Human immunodeficiency virus type 1 activation after blood transfusionTransfusion, 1996